The Correlation Between RIN3 Gene Methylation and Cognitive Impairment in Parkinson's Disease

Area of Science:

• Neuroscience
• Genetics
• Epigenetics

Background:

• Parkinson's disease (PD) is a common neurodegenerative disorder often accompanied by cognitive impairment.
• Abnormal DNA methylation is implicated in neurodegenerative diseases like PD.
• The RIN3 gene is involved in processes linked to cognitive function, but its role in PD-related cognitive decline is unexplored.

Purpose of the Study:

• To investigate the association between RIN3 gene methylation status and cognitive impairment in Parkinson's disease patients.
• To clarify the role of RIN3 gene methylation in the pathogenesis of Parkinson's disease.

Main Methods:

• The study included 51 Parkinson's disease (PD) patients and 50 healthy controls.
• Cognitive function was assessed using a cognitive scale.
• DNA methylation levels of the RIN3 gene in whole blood were analyzed and compared between groups, including PD patients with mild cognitive impairment (PD-MCI) and normal cognition (PD-NC).

Main Results:

• Patients with PD exhibited lower RIN3 gene methylation levels in whole blood compared to healthy controls (22.3% vs. 23.6%, P=0.009).
• Individuals with PD-MCI showed significantly lower RIN3 methylation levels than both the control group (21.3% vs. 23.6%, P<0.001) and the PD-NC group (21.3% vs. 23.3%, P=0.001).

Conclusions:

• RIN3 gene methylation is significantly associated with mild cognitive impairment in Parkinson's disease.
• RIN3 methylation may serve as a potential biomarker for predicting the development of PD-MCI.
• Clinical interventions and lifestyle modifications targeting methylation could influence disease progression.